Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptolide-Containing Formulation in ADPKD
NCT02115659Phase 3Unknown
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Apr 2014
- Primary completion
- May 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of triptolide in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Shanghai Changzheng Hospital. Status: unknown.
02
Drugs
triptolide
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT02115659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115659.